PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2024 Financial Results
PTC Therapeutics (NASDAQ: PTCT) has announced it will host a webcast conference call on Thursday, November 7, at 4:30 p.m. EST to discuss its third quarter 2024 financial results and provide a business update. Participants are advised to register in advance and dial in 15 minutes before the call to avoid delays. The webcast will be accessible through PTC's Investor Relations website, with a replay available for 30 days after the call.
PTC Therapeutics (NASDAQ: PTCT) ha annunciato che ospiterà una conferenza telefonica in webcast giovedì 7 novembre alle 16:30 EST per discutere i risultati finanziari del terzo trimestre 2024 e fornire un aggiornamento sull'azienda. I partecipanti sono invitati a registrarsi in anticipo e a effettuare la chiamata 15 minuti prima dell'inizio per evitare ritardi. Il webcast sarà accessibile attraverso il sito web delle Relazioni con gli Investitori di PTC, con una registrazione disponibile per 30 giorni dopo la chiamata.
PTC Therapeutics (NASDAQ: PTCT) ha anunciado que llevará a cabo una conferencia telefónica en webcast el jueves 7 de noviembre a las 4:30 p.m. EST para discutir sus resultados financieros del tercer trimestre de 2024 y proporcionar una actualización de negocios. Se aconseja a los participantes que se registren con antelación y llamen 15 minutos antes de la conferencia para evitar retrasos. El webcast será accesible a través del sitio web de Relaciones con Inversores de PTC, con una repetición disponible durante 30 días después de la llamada.
PTC Therapeutics (NASDAQ: PTCT)는 11월 7일 목요일 오후 4:30 EST에 웹캐스트 컨퍼런스 콜을 개최하여 2024년 3분기 재무 결과를 논의하고 사업 업데이트를 제공할 것이라고 발표했습니다. 참가자들은 사전에 등록하고 통화 15분 전에 전화를 걸어 지연을 피할 것을 권장합니다. 웹캐스트는 PTC의 투자자 관계 웹사이트를 통해 접근 가능하며, 통화 후 30일 동안 재생이 가능합니다.
PTC Therapeutics (NASDAQ: PTCT) a annoncé qu'il tiendrait une conférence téléphonique en webcast le jeudi 7 novembre à 16h30 EST pour discuter de ses résultats financiers du troisième trimestre 2024 et fournir une mise à jour sur l'entreprise. Les participants sont invités à s'inscrire à l'avance et à se connecter 15 minutes avant l'appel pour éviter des retards. Le webcast sera accessible via le site Web des relations avec les investisseurs de PTC, avec une rediffusion disponible pendant 30 jours après l'appel.
PTC Therapeutics (NASDAQ: PTCT) hat angekündigt, dass es am Donnerstag, den 7. November um 16:30 Uhr EST eine Webcast-Konferenzschaltung veranstalten wird, um die finanziellen Ergebnisse des dritten Quartals 2024 zu diskutieren und ein Unternehmens-Update bereitzustellen. Die Teilnehmer werden gebeten, sich im Voraus zu registrieren und 15 Minuten vor dem Anruf einzuwählen, um Verzögerungen zu vermeiden. Der Webcast wird über die Investor Relations-Website von PTC zugänglich sein, mit einer Wiederholung, die 30 Tage nach dem Anruf verfügbar ist.
- None.
- None.
WARREN, N.J., Oct. 24, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its third quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, Nov. 7, at 4:30 p.m. EST.
To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.
About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on X (formerly Twitter), and on LinkedIn.
For More Information:
Investors:
Investor Relations
+1 (908) 912-9848
ir@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-third-quarter-2024-financial-results-302285326.html
SOURCE PTC Therapeutics, Inc.
FAQ
When will PTC Therapeutics (PTCT) report Q3 2024 earnings?
How can I access PTC Therapeutics (PTCT) Q3 2024 earnings call?
How long will PTC Therapeutics (PTCT) Q3 2024 earnings call replay be available?
